2023-03-10 16:48:25 ET
- Kiromic BioPharma ( NASDAQ: KRBP ) has announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-30 effective on March 10, 2023.
- Kiromic common stock will begin trading on a split-adjusted basis when the market opens on March 13, 2023 under the existing trading symbol KRBP.
- As a result of the reverse stock split, the CUSIP number for the Company’s common stock will now be 497634204.
- Immediately after the reverse stock split becomes effective, the Company will have ~966,758 shares of common stock issued and outstanding.
For further details see:
Kiromic BioPharma announces 1-for-30 reverse stock split